image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

InnovaDerma

October 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IDP
  • Price:
  • 126.5p
InnovaDerma’s full year was in line with recently reduced expectations. Sales were up  21% to £10.7m (£0.3m shortfall attributed to timing and despatch of June sales into July), pretax profit was £0.7m/eps 2.2p and year-end cash was £1.9m. The statement also confirmed that Boots is to range SkinnyTan in 1,250 of its UK stores from February whilst Roots should be in 1,600 stores by the year-end. Finncap forecasts £1.7m pretax profit/eps 7.7p for this year. Chief executive Haris Chaudhry is keen for investors to put their money where his mouth is - whilst selling a further 1m shares himself. Written about at 130p in January ‘17, the shares soared to 410p but I suggested they had run ahead ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe